You are here:

Home
NICE Guidance
Conditions and diseases
Blood and immune system conditions
Blood and bone marrow cancers

Brentuximab vedotin for untreated advanced Hodgkin lymphoma (terminated appraisal)

Technology appraisal
Reference number: TA594
Published: 14 August 2019

Guidance
Tools and resources
History

Tools and resources

Tools to help you put the guidance into practice.

Guidance into practice

About the Into practice guide
Practical steps to improving the quality of care and services using NICE guidance